PT  - JOURNAL ARTICLE
AU  - Peter H Groves
AU  - Chris Pomfrett
AU  - Mirella Marlow
TI  - Review of the role of NICE in promoting the adoption of innovative cardiac technologies
AID  - 10.1136/heartjnl-2018-313256
DP  - 2018 Nov 01
TA  - Heart
PG  - 1817--1822
VI  - 104
IP  - 22
4099  - http://heart.bmj.com/content/104/22/1817.short
4100  - http://heart.bmj.com/content/104/22/1817.full
SO  - Heart2018 Nov 01; 104
AB  - The National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) promotes the adoption of innovative diagnostic and therapeutic technologies into National Health Service (NHS) clinical practice through the publication of guidance and briefing documents. Since the inception of the programme in 2009, there have been 7 medical technologiesguidance, 3 diagnostics guidance and 23 medtechinnovation briefing documents published that are relevant to the heart and circulation. Medical technologies guidance is published by NICE for selected single technologies if they offer plausible additional benefits to patients and the healthcare system. Diagnostic guidance is published for diagnostic technologies if they have the potential to improve health outcomes, but if their introduction may be associated with an increase in overall cost to the NHS. Medtechinnovation briefings provide evidence-based advice to those considering the implementation of new medical devices or diagnostic technologies. This review provides reference to all of the guidance and briefing medical technology documents that NICE has published that are relevant to the heart and circulation and reflect on their diverse recommendations. The interaction of MTEP with other NICE programmes is integral to its effectiveness and the means by which consistency is ensured across the different NICE programmes is described. The importance of the input of clinical experts from the cardiovascular professional community and the engagement by NICE with cardiovascular professional societies is highlighted as being fundamental to ensuring the quality of guidance outputs as well as to promoting their implementation and adoption.